KYUNG DONG PHARMACEUTICAL Co., Ltd 011040

KRX · South Korea · Health Technology

KRW 5,020.00+10.00 (+0.20%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

KYUNG DONG PHARMACEUTICAL Co., Ltd 011040

KRX · South Korea · Health Technology

KRW 5,020.00+10.00 (+0.20%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Company news

Yahoo FinanceAug 09, 2026

Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody

BOSTON, Aug. 09, 2026 (GLOBE NEWSWIRE) -- Kyungdong Pharmaceutical announced that it has successfully completed a cell line development campaign for a biosimilar antibody candidate, in collaboration with Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development. Through this collaboration, Kyungdong secured a high-performing production cell line for its next-generation biosimilar antibody candidate, laying the foundation for process development, larg

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.